The research antibodies and reagents market consists of sales of research antibodies, reagents and related services by entities (organizations, sole traders and partnerships) that produce research antibodies and reagents to diagnose and treat different diseases. The revenue generated by the market includes the sales of research antibodies in the form of primary and secondary antibodies extracted from sources such as mouse, rabbit and others, and reagents like stains & dyes, media & serum, fixatives, buffers, probe, solvents, enzymes and others. The companies involved in the research antibodies and reagents market are primarily engaged in developing antibodies and reagents for the application of proteomics, genomics, drug discovery and development by the pharmaceutical & biotechnology industries, academic & research institutes and contract research organizations.
The global research antibodies and reagents market is expected to grow from $10.35 billion in 2019 to $12.64 billion in 2020 at a compound annual growth rate (CAGR) of 22.08%. The growth is mainly due to the COVID-19 outbreak that has led to an increase in demand for antibodies to treat affected patients. The market is then expected to stabilize and reach $13.19 billion in 2023 at a CAGR of 1.43%.